Literature DB >> 23507140

MiR-449c targets c-Myc and inhibits NSCLC cell progression.

Li-Jun Miao1, Shi-Fu Huang, Zhen-Tao Sun, Zeng-Yan Gao, Rui-Xia Zhang, Ying Liu, Jing Wang.   

Abstract

MicroRNAs (miRNA) play an important role in tumorigenesis, proliferation, and differentiation. Altered miRNA expression in cancer indicates that miRNAs can function as tumor suppressors or oncogenes. MiR-449c downregulation in non-small cell lung cancer (NSCLC) compared with normal lung tissues was investigated in this study. NSCLC cell proliferation and invasion assays indicate that transfection of miR-449c expression plasmid inhibits the proliferation and invasion ability of NCI-H23 and NCI-H838 cells. In addition, miR-449c overexpression could suppress tumor growth in vivo. Morever, c-Myc was identified as a direct target gene of miR-449c. These findings clearly suggest that miR-449c downregulation and c-Myc amplification may be involved in the development of NSCLC.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507140     DOI: 10.1016/j.febslet.2013.03.006

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

1.  MiR-101 inhibits the proliferation and metastasis of lung cancer by targeting zinc finger E-box binding homeobox 1.

Authors:  Le Han; Wenjuan Chen; Yanmin Xia; Yangrong Song; Zheng Zhao; Hao Cheng; Tao Jiang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 2.  Oxidative stress response and Nrf2 signaling in aging.

Authors:  Hongqiao Zhang; Kelvin J A Davies; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2015-06-09       Impact factor: 7.376

3.  miR-449c inhibits migration and invasion of gastric cancer cells by targeting PFKFB3.

Authors:  Xin Chen; Anping Wang; Xinxia Yue
Journal:  Oncol Lett       Date:  2018-05-02       Impact factor: 2.967

4.  Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer.

Authors:  Xudong Chen; Guoqiang Zhao; Fuqing Wang; Fenglan Gao; Hailan Luo; Yuanyuan Wang; Yuwen Du; Xiaonan Chen; Changgui Xue; Ziming Dong; Guohua Song
Journal:  Tumour Biol       Date:  2014-08-06

5.  Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function.

Authors:  Masaaki Yamamoto; Anat Ben-Shlomo; Hiraku Kameda; Hidenori Fukuoka; Nan Deng; Yan Ding; Shlomo Melmed
Journal:  JCI Insight       Date:  2018-10-04

6.  MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3.

Authors:  Heying Chu; Xudong Chen; Huaqi Wang; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Ping Li; Juan Li; Jingxia Chang; Guoqiang Zhao; Guojun Zhang
Journal:  Tumour Biol       Date:  2013-11-29

7.  SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.

Authors:  Rafal Bartoszewski; Michal Dabrowski; Bogdan Jakiela; Sadis Matalon; Kevin S Harrod; Marek Sanak; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-05       Impact factor: 5.464

Review 8.  The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases.

Authors:  Leah Cushing; Zhihua Jiang; Pingping Kuang; Jining Lü
Journal:  Am J Respir Cell Mol Biol       Date:  2015-04       Impact factor: 6.914

9.  ATP promotes cell survival via regulation of cytosolic [Ca2+] and Bcl-2/Bax ratio in lung cancer cells.

Authors:  Shanshan Song; Krista N Jacobson; Kimberly M McDermott; Sekhar P Reddy; Anne E Cress; Haiyang Tang; Steven M Dudek; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-21       Impact factor: 4.249

10.  Roles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer.

Authors:  Wangjian Zha; Liu Cao; Ying Shen; Mao Huang
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.